Differential expression of perforin in cytotoxic lymphocyte in HIV/AIDS patients of China

Journal of Clinical Immunology

Volumn 26, Issue 4, 2006, Pages 339-346

  Qi, Wang ^a   Yongjun, Jiang ^b   Yanan, Wang ^b   Zining, Zhang ^b   Xiaoxu, Han ^b   Jing, Liu ^b   Hong, Shang ^b  

^a Shenyang Center for Disease Control and Prevention   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

AIDS; CD8; CTL; HIV; NK; Perforin

Indexed keywords

ANTIRETROVIRUS AGENT; CD16 ANTIGEN; EFAVIRENZ; INDINAVIR; PERFORIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL TYPE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STAINING;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHINA; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33745924387     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-006-9027-1     Document Type: Article

References (29)

1. Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, et al.: Unlocking the secrets of cytotoxic granule proteins. J Leuk Biol 70:18-29, 2001
2. Levy JA: The importance of innate system in controlling HIV infection and disease. Trends Immunol 22(6):312-316, 2001
3. + lymphocytes. Science 283:857-860, 1999
4. Lieberman J, Shankar P, Anjunath N, Andersson J: Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-linfection. Blood 98(6):1667-1677, 2001
5. - cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol 10:331-340, 1995
6. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, Pedersen BK: Detective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med 182:789-799, 1995
7. Miller J: The biology of natural killer cells in cancer, infection and pregnancy. Experimnetal Hematology 29:1157-1168, 2001
8. -1 infection. J Exp Med 193:169-180, 2001
9. Heintel T, Sester M, Rodriguez MM, Krieg C, Sester U, Wagner R, et al.: The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection. AIDS 16:1497-1501, 2002
10. +T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192(1):63-75, 2000
11. Portales P, Reynes I, Rouzier-Panis R, Baillat V, Clot J, Corbeau P: Perform expression in T cells and virological response to PEG-interferon alpha2b in HIV-1infection. AIDS 17:505-511, 2003
12. Preko PO, Jiang G, Frimpong G, Paiardini M, Barry A, McClure et al.: Immunophenotypic analysis in Ghanaians at different stages of HIV-1 infection. 15th AIDS Conference, 2004, A10555
13. Chen G, Shankar P, Lange C, Valdez H, Skolnik PR, Wu L, et al.: CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 98:156-164, 2001
14. Andersson I, Behhahani H, Lieberman I, Connick E, Landay A, Patterson B, et al.: Perform is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS 13:1295-1303, 1999
15. Benn S, Rutledge R, Folks T, Gold J, Baker L, McCormick I, et al.: Genomic hrterogeneity of AIDS retroviral isolates from North America and Zaire. Science 230:949-951, 1985
16. Yang OO, Sarkis PT, Trocha A, Kalams SA, Johnson RP, Walker BD. Impacts of avidity and specificity on the antiviral efficiency of HIV-1 specific CTL. J Immunol 171:3718-3724, 2003
17. Bouhlal H, Galon J, Kazatchchine MD, et al.: Soluble CD16 inhibits CR3(CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1. J Immunol 166:3377-3383, 2001
18. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 76:2421-2438, 1990
19. +NK and NKT peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166:6477-6482, 2001
20. Sondergaard SR, Ullum H, Skinhoj P, Pedersen BK: Epinephrine-induced mobilization of natural killer (NK) cells and NK-like T cells in HIV-infected patients. Cell Immunol 197:91-98, 1999
21. + natural killer cell subset during HIV infection. Cytometry 22(1):10-15, 1995
22. + natural killer cells. APMIS 108:831-837, 2001
23. Brenner BG, Gryllis C, Gornitsky M, Wainberg MA: Changes in natural immunity during the course of HIV-1 infection. Clin Exp Immunol 93:142-148, 1993
24. Portales P, Reynes J, Pinet V, Rouzier-Panis R, Baillat V, Clot J, et al.: Interferon-α restores HIV-induced alteration of natural killer cell perform expression in vivo. AIDS 17:495-504, 2003
25. Chehimi J, Bandyopadhyay S, Prakash K, Perussia B, Hassan NF, Kawashima H, et al.: In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates. J Virol 65:1812-1822, 1991
26. Kinter A, Fauci AS: Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement. Immunol Res 15:1-5, 1996
27. +T cells by perform. Eur J Immunol 29:3262-3272, 1999
28. Jiang Y, Shang H, Zhang Z, Diao Y, Dai D, Geng W, et al.: Alterations of natural killer cell and T-lymphocyte counts in adults infected with human immunodeficiency virus through blood and plasma sold in the past in China and in whom infection has progressed slowly over a long period. Clin Diagn Lab Immunol 12(11):1275-1279, 2005
29. -treated individuals. AIDS 18:859-869, 2004